title: Neurohumoral behavior in recipients of cardiac pacemakers controlled by a closed-loop autonomic nervous system-driven sensor.
abstract: The purpose of a sensor-driven pacing system is to physiologically correct chronotropic incompetence (CI). The aim of this study was to evaluate the changes in heart rate provided by a sympathetically driven pacemaker (PM) compared with normal sinus function (NSF). Nine men and six women (age 37-80 years) with AV block and a PM controlled by a closed-loop system were studied. Group I included eight patients with CI, and group II included seven patients with NSF. All patients underwent Valsalva maneuver and tilt table testing with measurements of plasma catecholamines and renin activity. Pacing was initially programmed in the DDDC mode at a lower rate (60 ppm) and upper rate limit (0.85 x [220 - age]), then in DDDR in group I and VVIR in group II. The second phase of the study consisted of nitroglycerin and phenylephrine infusions, and the third phase of physiological provocative maneuvers. The second and third phases were performed in three patients from each group with sensor activity On and Off. In group I, heart rate changed during tilt only in the DDDR mode. In group II, heart rate changes were comparable in both modes. Catecholamine levels in group I were higher during DDDC than during DDDR pacing (P < 0.05). In group I, heart rate did not change during phases II and IV of the Valsalva maneuver in the DDDC mode, but behaved nearly physiologically after sensor activation. A late and a paradoxical response to nitroglycerin was observed in groups I and II and to phenylephrine in group I. During physiological maneuvers, significantly greater variations in heart rate were observed during DDDR than during DDDC pacing. Sympathetic SDP provides physiological modulations of the heart rate were provided by a sympathetically driven pacing system in patients with AV block and CI.
authors.affiliation: Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil. martino@incor.usp.br
authors.forename: M
authors.initials: M
authors.lastname: Martinelli Filho
authors.forename: S A
authors.initials: SA
authors.lastname: Nishióka
authors.forename: H
authors.initials: H
authors.lastname: Lopes
authors.forename: J C
authors.initials: JC
authors.lastname: Oliveira
authors.forename: A A
authors.initials: AA
authors.lastname: Pedrosa
authors.forename: S F
authors.initials: SF
authors.lastname: Siqueira
authors.forename: R
authors.initials: R
authors.lastname: Costa
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001341:Autonomic Nervous System / Q000503:physiopathology*; D001794:Blood Pressure / Q000187:drug effects; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D004837:Epinephrine / Q000097:blood; D005260:Female; D006327:Heart Block / Q000097:blood / Q000503:physiopathology* / Q000628:therapy; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000494:pharmacology; D009638:Norepinephrine / Q000097:blood; D010138:Pacemaker, Artificial; D010656:Phenylephrine / Q000494:pharmacology; D011446:Prospective Studies; D012083:Renin / Q000097:blood; D018667:Tilt-Table Test; D014636:Valsalva Maneuver
chemical_list: D010656:Phenylephrine; D012083:Renin; D005996:Nitroglycerin; D009638:Norepinephrine; D004837:Epinephrine